The first case, reported by Loustau et al. in 2009, presented a 57-year-old patient diagnosed with ankylosing spondylitis who, due to resistance to non-steroidal anti-inflammatory drugs, was started on treatment with the TNF-α inhibitor infliximab. This evidence concerns the gene TNF and ankylosing spondylitis.